These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The pharmacokinetics of Norpace. Karim A Angiology; 1975 Jan; 26(1 Pt 2):85-98. PubMed ID: 1090217 [No Abstract] [Full Text] [Related]
4. [Pharmacokinetic and metabolic study of disopyramide in oral and intravenous administration]. De Graeve J; Kremers P; Gielen JE Therapie; 1977; 32(2):195-204. PubMed ID: 898127 [No Abstract] [Full Text] [Related]
5. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability. Bryson SM; Whiting B; Lawrence JR Br J Clin Pharmacol; 1978 Nov; 6(5):409-19. PubMed ID: 728284 [TBL] [Abstract][Full Text] [Related]
6. Influence of renal failure on disopyramide pharmacokinetics [proceedings]. Henry JA; Johnston A; Warrington SJ; Hamer NA Br J Clin Pharmacol; 1979 Apr; 7(4):427P-428P. PubMed ID: 444377 [No Abstract] [Full Text] [Related]
8. Pharmacokinetics of disopyramide administered by intramuscular, intravenous and oral routes to normal volunteers [proceedings]. Ashford JJ; Carmichael D; Kidner PH Br J Pharmacol; 1979 Jul; 66(3):442P-443P. PubMed ID: 526732 [No Abstract] [Full Text] [Related]
9. Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia. Rangno RE; Warnica W; Ogilvie RI; Kreeft J; Bridger E J Int Med Res; 1976; 4(1 Suppl):54-8. PubMed ID: 1026530 [No Abstract] [Full Text] [Related]
10. Placental and milk transfer of disopyramide and metabolites. Karim A; Kook C; Campion J Drug Metab Dispos; 1978; 6(3):346-8. PubMed ID: 26557 [No Abstract] [Full Text] [Related]
11. The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans. Aitio ML; Allonen H; Kanto J; Mäntylä R Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):219-26. PubMed ID: 7095921 [TBL] [Abstract][Full Text] [Related]
12. Disopyramide plasma and myocardial tissue concentrations as they relate to antiarrhythmic activity. Patterson E; Stetson P; Lucchesi BR J Cardiovasc Pharmacol; 1979; 1(5):541-50. PubMed ID: 94410 [TBL] [Abstract][Full Text] [Related]
13. Disopyramide pharmacokinetics during recovery from myocardial infarction. Bryson SM; Cairns CJ; Whiting B Br J Clin Pharmacol; 1982 Mar; 13(3):417-21. PubMed ID: 7059444 [TBL] [Abstract][Full Text] [Related]
14. Liquid chromatographic analysis of disopyramide and its mono-N-dealkylated metabolite. Lima JJ Clin Chem; 1979 Mar; 25(3):405-8. PubMed ID: 262180 [TBL] [Abstract][Full Text] [Related]
15. Species differences in the biotransformation of a new antiarrhythmic agent: disopyramide phosphate. Karim A; Ranney RE; Kraychy S J Pharm Sci; 1972 Jun; 61(6):888-93. PubMed ID: 5046104 [No Abstract] [Full Text] [Related]
16. [Pharmacokinetic study of disopyramide in normal man]. Mallein R; Rondelet J; Boucherat M; Ksavrelof M; Pignat M Therapie; 1978; 33(4):463-73. PubMed ID: 734626 [No Abstract] [Full Text] [Related]
17. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog. Karim A; Kook C; Novotney RL; Zagarella J; Campion J Drug Metab Dispos; 1978; 6(3):338-45. PubMed ID: 26556 [TBL] [Abstract][Full Text] [Related]